Colleen McCormick
Papers
2
Total Citations
32
H-Index
2
About
Colleen McCormick is a leading gynecologic oncologist and clinical trialist whose work has fundamentally reshaped surgical standards for early-stage cervical cancer. Her research centers on the comparative effectiveness of minimally invasive versus open surgical approaches, with a particular focus on robotic-assisted radical hysterectomy. McCormick is best known as the principal investigator of the landmark ROCC/GOG-3043 trial, a randomized non-inferiority study that directly challenges the paradigm shift triggered by the 2018 LACC trial. By rigorously comparing robotic versus open radical hysterectomy, her work addresses critical questions about oncologic safety and perioperative outcomes in an era of evolving surgical technology. The 2022 protocol publication (24 citations) and the 2025 results paper (8 citations) represent a pivotal contribution to the field, providing high-level evidence that informs clinical decision-making and patient counseling. McCormick’s research has direct implications for surgical training, hospital resource allocation, and the ongoing debate over minimally invasive surgery in oncology. Her work exemplifies how rigorous trial design can resolve controversies and set new standards of care in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2